Treatment for human memory impairment associated with aging
Patent 4385053 Issued on May 24, 1983. Estimated Expiration Date: 
March 11, 2001. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 11, 2001. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsApplicationNo. 06/242750 filed on 03/11/1981US Classes:514/78, Lecithins514/424, Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding514/879SenilityExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassesA61K 31/685 (20060101)A61K 31/683 (20060101) A61K 31/40 (20060101) AbstractA process is disclosed for treating human memory impairment associated with aging, such as occurs in Alzheimer's disease, by administering a central nervous system cholinergic precursor such as lecithin or a choline salt in construction with a metabolic enhancer such as piracetam.Other References
| |
